García Campelo, M.R.; Arriola, E.; Campos Balea, B.; López-Brea, M.; Fuentes-Pradera, J.; de Castro Carpeno, J.; Aguado, C.; Pérez Parente, D.; de Oro Pulido, F.; Ruiz-Gracia, P.;
et al. PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis. J. Clin. Med. 2021, 10, 4583.
https://doi.org/10.3390/jcm10194583
AMA Style
García Campelo MR, Arriola E, Campos Balea B, López-Brea M, Fuentes-Pradera J, de Castro Carpeno J, Aguado C, Pérez Parente D, de Oro Pulido F, Ruiz-Gracia P,
et al. PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis. Journal of Clinical Medicine. 2021; 10(19):4583.
https://doi.org/10.3390/jcm10194583
Chicago/Turabian Style
García Campelo, María Rosario, Edurne Arriola, Begoña Campos Balea, Marta López-Brea, José Fuentes-Pradera, Javier de Castro Carpeno, Carlos Aguado, Diego Pérez Parente, Fidel de Oro Pulido, Pedro Ruiz-Gracia,
and et al. 2021. "PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis" Journal of Clinical Medicine 10, no. 19: 4583.
https://doi.org/10.3390/jcm10194583
APA Style
García Campelo, M. R., Arriola, E., Campos Balea, B., López-Brea, M., Fuentes-Pradera, J., de Castro Carpeno, J., Aguado, C., Pérez Parente, D., de Oro Pulido, F., Ruiz-Gracia, P., & Rodríguez-Abreu, D.
(2021). PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis. Journal of Clinical Medicine, 10(19), 4583.
https://doi.org/10.3390/jcm10194583
